Spots Global Cancer Trial Database for pancreatic cancer stage iv
Every month we try and update this database with for pancreatic cancer stage iv cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| IORT Versus CCRT for Pancreatic Cancer | NCT02981641 | Pancreatic Canc... | Intraoperative ... Sequential chem... Three dimension... Concurrent chem... | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer | NCT04137822 | Pancreas Cancer Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... | IMM-101 | 18 Years - | Impatients N.V. trading as myTomorrows | |
| IORT Versus CCRT for Pancreatic Cancer | NCT02981641 | Pancreatic Canc... | Intraoperative ... Sequential chem... Three dimension... Concurrent chem... | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer | NCT04953962 | Pancreatic Canc... | CBP501 (16) CBP501 (25) Cisplatin Nivolumab | 18 Years - | CanBas Co. Ltd. | |
| Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) | NCT05642962 | Metastatic Panc... Metastatic Panc... Metastatic Panc... Metastatic Panc... Pancreatic Carc... Pancreatic Carc... Pancreatic Carc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... PDAC PDAC - Pancreat... | Pertzye | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer | NCT04406831 | Pancreatic Canc... Pancreatic Canc... Pancreatic Duct... Pancreatic Neop... | Blood draw | 18 Years - | Nuvance Health | |
| Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells | NCT04628806 | Melanoma Stage ... Sarcoma Squamous Cell C... Pancreatic Canc... Prostate Cancer Breast Cancer S... | CTC isolation b... | 18 Years - | Charite University, Berlin, Germany | |
| A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer | NCT04674956 | Pancreatic Canc... Pancreatic Canc... | Camrelizumab Paclitaxel(Albu... Placebo | 18 Years - | RenJi Hospital | |
| Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer | NCT06017284 | Pancreatic Canc... Chemotherapy-in... | Thalidomide Nab paclitaxel Gemcitabine Placebo | 18 Years - 80 Years | Fudan University | |
| Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer | NCT03412799 | Pancreatic Canc... Pancreatic Canc... Stage IV Pancre... | SBP-101 nab-paclitaxel Gemcitabine Inj... | 18 Years - | Panbela Therapeutics, Inc. | |
| Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients With Unresectable Pancreatic Cancer. | NCT03252808 | Pancreatic Canc... Pancreatic Canc... | TBI-1401(HF10) Gemcitabine Nab-paclitaxel TS-1 | 20 Years - | Takara Bio Inc. | |
| Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells | NCT04628806 | Melanoma Stage ... Sarcoma Squamous Cell C... Pancreatic Canc... Prostate Cancer Breast Cancer S... | CTC isolation b... | 18 Years - | Charite University, Berlin, Germany | |
| Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer | NCT04953962 | Pancreatic Canc... | CBP501 (16) CBP501 (25) Cisplatin Nivolumab | 18 Years - | CanBas Co. Ltd. | |
| Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic Cancer | NCT03236883 | Pancreatic Canc... Pancreatic Canc... | Gemcitabine GPBSC | 18 Years - 80 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer | NCT04137822 | Pancreas Cancer Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... | IMM-101 | 18 Years - | Impatients N.V. trading as myTomorrows | |
| Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer | NCT03412799 | Pancreatic Canc... Pancreatic Canc... Stage IV Pancre... | SBP-101 nab-paclitaxel Gemcitabine Inj... | 18 Years - | Panbela Therapeutics, Inc. | |
| SHR- 1210 Combined With Paclitaxel (Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer | NCT04181645 | Pancreatic Canc... | Biological: SHR... | 18 Years - | RenJi Hospital | |
| Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer | NCT05254171 | Pancreatic Canc... Pancreatic Duct... Pancreatic Canc... | SBP-101 Nab-paclitaxel Gemcitabine Placebo | 18 Years - | Panbela Therapeutics, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
